These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Ono H, Ono Y, Frohlich ED. Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038 [Abstract] [Full Text] [Related]
3. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats. Ono Y, Ono H, Frohlich ED. J Hypertens; 1996 Jul; 14(7):823-8. PubMed ID: 8818920 [Abstract] [Full Text] [Related]
4. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model. Zhou X, Ono H, Ono Y, Frohlich ED. J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661 [Abstract] [Full Text] [Related]
5. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR. Zhou X, Matavelli LC, Ono H, Frohlich ED. Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021 [Abstract] [Full Text] [Related]
9. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Hypertension; 2001 Dec 01; 38(6):1300-6. PubMed ID: 11751707 [Abstract] [Full Text] [Related]
12. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Hypertension; 1996 Jan 01; 27(1):49-55. PubMed ID: 8591887 [Abstract] [Full Text] [Related]